Novartis Profit Tops Estimates as Cancer Drug Sales Offset Entresto Decline
2026-07-21 06:57:15
Novartis AG reported higher-than-expected profit last quarter, according to Bloomberg, as newer cancer medicines helped offset declining sales of its aging blockbuster Entresto to generic rivals.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
